pramipexole
UkraineDrugs containing this active substance
-
The drug is used for the treatment of signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome in adults.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
Manufacturer: Specifar SA
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome in adults.
Form: tablets
Active substance Dosage pramipexole 0.088 mg ATC: N04BC05
Manufacturer: Specifar SA
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome in adults.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
Manufacturer: Specifar SA
-
The drug is prescribed to adults for the treatment of signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG
-
The drug is prescribed to adults for the treatment of signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate or severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG
-
The drug is intended for adults for the treatment of signs and symptoms of idiopathic Parkinson's disease. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 0.26 mg ATC: N04BC05
-
The drug is intended for adults for the treatment of signs and symptoms of idiopathic Parkinson's disease. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 0.52 mg ATC: N04BC05
-
The drug is indicated for adults for the treatment of signs and symptoms of idiopathic Parkinson's disease. It can be used as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 1.05 mg ATC: N04BC05
-
The drug is used to treat symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used to treat symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.35 mg ATC: N04BC05
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used to treat symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.088 mg ATC: N04BC05
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 1.1 mg ATC: N04BC05
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.35 mg ATC: N04BC05
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 0.26 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 0.52 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat lower urinary tract functional disorders in benign prostatic hyperplasia (enlargement of the prostate gland).
Form: tablets, extended-release
Active substance Dosage pramipexole 1.05 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 1.57 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 2.1 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 2.62 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be used either as monotherapy or in combination with levodopa.
Form: tablets, extended-release
Active substance Dosage pramipexole 3.15 mg ATC: N04BC05
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.25 mg ATC: N04BC05
Manufacturer: San Pharmaceutical Industries Ltd
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 1 mg ATC: N04BC05
Manufacturer: San Pharmaceutical Industries Ltd
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.25 mg ATC: N04BC05
Manufacturer: Farmas Start LLC
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 1.0 mg ATC: N04BC05
Manufacturer: Farmas Start LLC
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.25 mg ATC: N04BC05
Manufacturer: Farmas Start LLC
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 1.0 mg ATC: N04BC05
Manufacturer: Farmas Start LLC
-
The drug is used to treat the symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
Manufacturer: Interkhim Limited Liability Partnership
-
The drug is used to treat the symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
Manufacturer: Interkhim Limited Liability Partnership
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.25 mg ATC: N04BC05
Manufacturer: LLC "Kharkiv Pharmaceutical Enterprise "Zdorovya Narodu"
-
The drug is used to treat the signs and symptoms of Parkinson's disease in adults (either alone or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 1 mg ATC: N04BC05
Manufacturer: LLC "Kharkiv Pharmaceutical Enterprise "Zdorovya Narodu"
-
The drug is used to treat the signs and symptoms of idiopathic Parkinson's disease. It can be used either as monotherapy or in combination with levodopa, particularly in the late stages of the disease.
Form: tablets, extended-release
Active substance Dosage pramipexole 0.52 mg ATC: N04BC05
Manufacturer: Laboratorios Normon, S.A.
-
The drug is used to treat the signs and symptoms of idiopathic Parkinson's disease. It can be used either as monotherapy or in combination with levodopa, particularly in the late stages of the disease when the effect of levodopa becomes unstable.
Form: tablets, extended-release
Active substance Dosage pramipexole 1.05 mg ATC: N04BC05
Manufacturer: Laboratorios Normon, S.A.
-
The drug is prescribed for adults for the treatment of signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
-
The drug is prescribed for adults to treat the signs and symptoms of Parkinson's disease (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
-
The drug is used for the treatment of signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.18 mg ATC: N04BC05
Manufacturer: Torrent Pharmaceuticals Ltd
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.175 mg ATC: N04BC05
Manufacturer: Alembic Pharmaceuticals Limited
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05
Manufacturer: Alembic Pharmaceuticals Limited